In addition, it has been found that this miRNA acts as a tumour suppressor by directly regulating the Cyb561/ROS pathway’s signalling in acute myeloid leukaemia [73], and that this molecule mediates carcinogenic processes in colorectal cancer by directly regulating ITGA6 and ITGB [74] and those in prostate cancer by regulating CTHRC1 [75]. The gene discussed is CTHRC1; the disease is acute myeloid leukemia.